TFPI2 promotes NK cell–mediated glioblastoma killing through adhesion and checkpoint control

TFPI2 способствует уничтожению глиобластомы естественными киллерами через адгезию и контроль контрольных точек
Xin Ni Mu, Dongpeng Zheng, Fengqi Li, Z H Zhang, Yunyi Dong, X Zhang, Xueren Li, Jingyue Yang, Shouchun Peng, Budong Chen, Shupeng Sun, Zichuan Liu, Fengqi Li
2026-06-18

ICAM1-mediated adhesionIL1β/TNFα NFκB signalingNK cell–glioblastoma cross talkSIGLEC15 immune checkpointTFPI2
Immune-mediated killing triggers dynamic transcriptional adaptations in tumor cells that can reciprocally regulate the cytolytic process. Unraveling such feedback mechanisms is crucial for advancing cancer immunotherapy. Here, we identified tissue factor pathway inhibitor 2 (TFPI2) as a central node in natural killer (NK)-glioblastoma cross talk. Using transcriptomic and functional approaches, we demonstrated that NK cell attack induces TFPI2 expression in glioblastoma cells via IL1β- and TNFα-driven activation of NFκB signaling. TFPI2 not only restrains tumor proliferation by suppressing the POU2F2-CCND1 axis but also enhances NK cytotoxicity through two complementary mechanisms: It supports optimal ICAM1 expression to promote NK-tumor adhesion, and it selectively represses the immune checkpoint molecule SIGLEC15, restoring NK cell effector function. In vivo, loss of TFPI2 accelerates glioblastoma progression and abrogates the efficacy of adoptive NK cell therapy in a context-dependent manner; the functionality is likely restricted to tumors retaining the capacity for TFPI2 induction upon inflammatory stimuli. Our findings identified the TFPI2-ICAM1 and TFPI2-SIGLEC15 axes as conditional regulators of immune-tumor adhesion and checkpoint control, supporting TFPI2 as a candidate therapeutic target for a subset of glioblastomas amenable to inflammatory reprogramming.
1
Loss of TFPI2 accelerates glioblastoma progression and abolishes adoptive NK cell therapy efficacy unless tumors can induce TFPI2 upon inflammatory stimuli.
2
NK cell attack induces TFPI2 expression in glioblastoma cells via IL1β- and TNFα-driven NFκB activation.
3
TFPI2 enhances NK cytotoxicity by supporting ICAM1 expression, promoting NK–tumor adhesion.
4
TFPI2 restrains tumor proliferation by suppressing the POU2F2-CCND1 axis.
5
TFPI2 selectively represses the immune checkpoint SIGLEC15, restoring NK cell effector function.

Tissue factor pathway inhibitor 2 (TFPI2) in glioblastoma cells during NK cell interaction

TFPI2's roles and mechanisms in modulating NK cell–mediated glioblastoma killing, specifically its regulation by NK-induced IL1β/TNFα–NFκB signaling, suppression of the POU2F2-CCND1 proliferation axis, promotion of ICAM1-dependent NK–tumor adhesion, and repression of the immune checkpoint SIGLEC15

Publication Details
Publication Date
2026-06-18
Journal
Publisher
ISSN
Cited by
0
Access Type
Author Information
Authors
Xin Ni Mu
Dongpeng Zheng
Fengqi Li
Z H Zhang
Yunyi Dong
X Zhang
Xueren Li
Jingyue Yang
Shouchun Peng
Budong Chen
Shupeng Sun
Zichuan Liu
Fengqi Li
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%